89bio, Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported net loss was USD 51.68 million compared to USD 28.84 million a year ago. Basic loss per share from continuing operations was USD 0.54 compared to USD 0.54 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.305 USD | +4.86% | -0.18% | -25.65% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-25.65% | 78Cr | |
+16.73% | 12TCr | |
+13.04% | 11TCr | |
-5.80% | 2.48TCr | |
+1.69% | 2.25TCr | |
-10.09% | 1.83TCr | |
-40.52% | 1.63TCr | |
-14.00% | 1.53TCr | |
+1.18% | 1.41TCr | |
+24.18% | 1.17TCr |
- Stock Market
- Equities
- ETNB Stock
- News 89bio, Inc.
- 89bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024